ATXN3 and colorectal carcinoma: We had access to longitudinal cohort data from EUROSCA, RISCA, ESMI & SCA Registry, and CRC-SCA that comprise together more than 5500 visits of more than 1400 SCA1, SCA2, SCA3, and SCA6 mutation carriers.